The December 2018 Farm Bill marked a new era for federally legal hemp and hemp-derived
products, including CBD. However, navigating this rapidly evolving landscape requires careful
attention to complex regulations. Notably, the U.S. Drug Enforcement Agency (DEA) proposed
an interim final rule on August 21, 2020, stating that any material with more than 0.3% THC on
a dry-weight basis remains classified as a Schedule I substance—a critical area of concern for the
hemp industry.
As the regulatory environment continues to change, start-ups, existing business owners, and
investors involved in cannabis cultivation, manufacturing, transportation, dispensaries, and
regulatory compliance face significant challenges. The Law Office of Kimberly R. Simms is
dedicated to helping these key players navigate these complexities and plan effectively for
success. In such a dynamic sector, failing to stay ahead of regulatory changes can lead to missed
opportunities and setbacks.
Business Formation and Strategy
Corporate Governance
Commercial Transactions
I Contract drafting and review
I Negotiation of contracts
I Mergers and Acquisitions
Licensing and Permits
Real Estate and Land Use
Due Diligence and Risk Evaluation
Partnership Dissolution & Business Wind-Up Services